Cargando…

A Novel Orthotopic Patient-Derived Xenograft Model of Radiation-Induced Glioma Following Medulloblastoma

SIMPLE SUMMARY: Radiation-induced glioma (RIG) is a highly aggressive brain cancer arising as a consequence of radiation therapy, for which there is currently no effective treatment. In order to test new drugs in the hope of finding more effective therapies, we need mouse models that faithfully repl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitehouse, Jacqueline P., Howlett, Meegan, Hii, Hilary, Mayoh, Chelsea, Wong, Marie, Barahona, Paulette, Ajuyah, Pamela, White, Christine L., Buntine, Molly K., Dyke, Jason M., Lee, Sharon, Valvi, Santosh, Stanley, Jason, Andradas, Clara, Carline, Brooke, Kuchibhotla, Mani, Ekert, Paul G., Cowley, Mark J., Gottardo, Nicholas G., Endersby, Raelene
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7600047/ https://www.ncbi.nlm.nih.gov/pubmed/33053751 http://dx.doi.org/10.3390/cancers12102937

Ejemplares similares

DIPG-50. A NOVEL ORTHOTOPIC PATIENT-DERIVED XENOGRAFT MODEL OF RADIATION-INDUCED GLIOMA
por: Whitehouse, Jacqueline, et al.
Publicado: (2020)

In vivo loss of tumorigenicity in a patient-derived orthotopic xenograft mouse model of ependymoma
por: Whitehouse, Jacqueline P., et al.
Publicado: (2023)

Veliparib Is an Effective Radiosensitizing Agent in a Preclinical Model of Medulloblastoma
por: Buck, Jessica, et al.
Publicado: (2021)

BIOL-12. ENHANCING IMMUNE-MEDIATED TUMOR CONTROL IN MURINE MODELS OF GROUP 3 MEDULLOBLASTOMA
por: Abbas, Zahra, et al.
Publicado: (2023)

Assessment of Cannabidiol and Δ9-Tetrahydrocannabiol in Mouse Models of Medulloblastoma and Ependymoma
por: Andradas, Clara, et al.
Publicado: (2021)

RONC-07. Fractionated radiotherapy is required to accurately mimic neurostructural late effects in preclinical models
por: Whitehouse, Jacqueline, et al.
Publicado: (2022)

Conventional Therapies Deplete Brain-Infiltrating Adaptive Immune Cells in a Mouse Model of Group 3 Medulloblastoma Implicating Myeloid Cells as Favorable Immunotherapy Targets
por: Abbas, Zahra, et al.
Publicado: (2022)

RONC-02. MEASURING THE EFFECT OF CLINICALLY-RELEVANT RADIOTHERAPY PROTOCOLS ON THE JUVENILE MOUSE BRAIN
por: Buck, Jessica, et al.
Publicado: (2020)

Defining the molecular features of radiation-induced glioma: A systematic review and meta-analysis
por: Whitehouse, Jacqueline P, et al.
Publicado: (2021)

MOMC-5. Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura, et al.
Publicado: (2021)

Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma
por: Genovesi, Laura A., et al.
Publicado: (2021)

A Pre-Clinical Assessment of the Pan-ERBB Inhibitor Dacomitinib in Pediatric and Adult Brain Tumors
por: Endersby, Raelene, et al.
Publicado: (2018)

The Role of Cannabinoids as Anticancer Agents in Pediatric Oncology
por: Andradas, Clara, et al.
Publicado: (2021)

HGG-20. NOVEL PAEDIATRIC CASE OF A SPINAL HIGH-GRADE ASTROCYTOMA WITH PILOID FEATURES IN A PATIENT WITH NOONAN SYNDROME
por: Staunton, Jordan, et al.
Publicado: (2023)

A novel technique of serial biopsy in mouse brain tumour models
por: Rogers, Sasha, et al.
Publicado: (2017)

Editorial: Bench to bedside: translating pre-clinical research into clinical trials for childhood brain tumors
por: Endersby, Raelene, et al.
Publicado: (2023)

Histone H3-wild type diffuse midline gliomas with H3K27me3 loss are a distinct entity with exclusive EGFR or ACVR1 mutation and differential methylation of homeobox genes
por: Ajuyah, Pamela, et al.
Publicado: (2023)

Efficacy of MEK inhibition in a recurrent malignant peripheral nerve sheath tumor
por: Nagabushan, Sumanth, et al.
Publicado: (2021)

Long-term outcomes of symptomatic optic pathway glioma: 32-year experience at a single Western Australian tertiary pediatric oncology center
por: Rajagopal, Revathi, et al.
Publicado: (2023)

Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group
por: Gottardo, Nicholas G., et al.
Publicado: (2013)

Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
por: Sandén, Emma, et al.
Publicado: (2017)

Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
por: Krausert, Sonja, et al.
Publicado: (2022)

Carbon ion radiotherapy eradicates medulloblastomas with chromothripsis in an orthotopic Li-Fraumeni patient-derived mouse model
por: Simovic, Milena, et al.
Publicado: (2021)

High-Throughput Drug Screening of Primary Tumor Cells Identifies Therapeutic Strategies for Treating Children with High-Risk Cancer
por: Mayoh, Chelsea, et al.
Publicado: (2023)

Genetic alterations of TP53 and OTX2 indicate increased risk of relapse in WNT medulloblastomas: “it’s a numbers game”—implications for WNT medulloblastoma dose-reduction clinical trials
por: Gottardo, Nicholas G.
Publicado: (2022)

MB3W1 is an orthotopic xenograft model for anaplastic medulloblastoma displaying cancer stem cell- and Group 3-properties
por: Dietl, Sebastian, et al.
Publicado: (2016)

MODL-27. MEK INHIBITION WITH TRAMETINIB SLOWS PROGRESSION OF MEDULLOBLASTOMA AND ATYPICAL TERATOID RHABDOID TUMOR IN ORTHOTOPIC XENOGRAFT MURINE MODEL
por: Mushrif, Sujata, et al.
Publicado: (2020)

Advances in CAR T cell immunotherapy for paediatric brain tumours
por: Rao, Padmashree, et al.
Publicado: (2022)

Chemotherapy-induced peripheral neuropathy in children and adolescent cancer patients
por: Tay, Nicolette, et al.
Publicado: (2022)

Spatial heterogeneity in medulloblastoma
por: Morrissy, A Sorana, et al.
Publicado: (2017)

Clinical evidence for synergy between immunotherapy and radiotherapy (SITAR)
por: Gill, Suki, et al.
Publicado: (2022)

DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

Oncolytic Herpes Virus rRp450 Shows Efficacy in Orthotopic Xenograft Group 3/4 Medulloblastomas and Atypical Teratoid/Rhabdoid Tumors
por: Studebaker, Adam W., et al.
Publicado: (2017)

Medulloblastoma stem cells: Promising targets in medulloblastoma therapy
por: Huang, Guo‐Hao, et al.
Publicado: (2016)

Illuminating Medulloblastoma
por: Rastan, Avesta, et al.
Publicado: (2019)

Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis
por: Manoharan, Neevika, et al.
Publicado: (2021)

Orthotopic models of pediatric brain tumors in zebrafish
por: Eden, Christopher J., et al.
Publicado: (2014)

From signalling pathways to targeted therapies: unravelling glioblastoma’s secrets and harnessing two decades of progress
por: Dewdney, Brittany, et al.
Publicado: (2023)

Hepatic Sinusoidal Obstruction Syndrome During Chemotherapy for Childhood Medulloblastoma: Report of a Case and Review of the Literature
por: Kotecha, Rishi S., et al.
Publicado: (2014)

Fatal Emmonsia sp. Infection and Fungemia after Orthotopic Liver Transplantation
por: Kappagoda, Shanthi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_bs8mookq5s8md8jseu0ioku2pd